"Oncology Meeting Innovations’ (OMI’s) Best Practices in Bladder Cancer provides an interactive platform to discuss recent developments in the treatment of bladder cancer. Attendees will apply information in case-based learning and discussions. Topics will include Recent Updates on Checkpoint Inhibitors for Untreated Bladder Cancer and New Targets in the Treatment of Advanced Bladder Cancer. The […]
"Oncology Meeting Innovations' (OMI's) Web Series on Gastrointestinal Malignancies engages local treating physicians to discuss the current treatment options in colorectal cancer and GIST. Topics will include Incorporating Chemo-free Options into mCRC Therapies as well as Treatment options for Multi-treated GIST. After each presentation, attendees will have the opportunity to pose questions to the KOL […]
"Oncology Meeting Innovations' (OMI's) Virtual Regional Summit on B-cell Malignancies assembles community physicians in a 3-hour program in which KOLs will present their current approaches to B-cell malignancies. Topics include Optimising Ibrutinib Therapy for Patients with CLL, Targeted Approaches to Follicular Lymphoma, Expanding the Use of CAR-T Therapy in B-cell NHL, and Current Approaches to […]
"Oncology Meeting Innovations’ (OMI’s) Best Practices in Bladder Cancer provides an interactive platform to discuss recent developments in the treatment of bladder cancer. Attendees will apply information in case-based learning and discussions. Topics will include Recent Updates on Checkpoint Inhibitors for Untreated Bladder Cancer and New Targets in the Treatment of Advanced Bladder Cancer. The […]
"Oncology Meeting Innovations' (OMI's) Virtual Regional Summit on Genitourinary Malignancies assembles community physicians in a 3-hour program in which KOLs will present their current approaches to genitourinary malignancies. Topics include New Targets in Bladder Cancer Therapy and Targeted Approaches for Prostate Cancer. After each presentation, audience members will have the opportunity to pose questions to […]
Relapsed/Refractory Multiple Myeloma
CAR-T
Bispecific Antibodies